Sector revisions Charles River Laboratories International, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. Other stock markets 2026-06-08			5-day change	1st Jan Change
148.34 ^CHF	0.00%		0.00%	-

Jun. 18	Charles River Laboratories International, Inc. and Eli Lilly and Company Enter Collaboration to Optimize Ai/Ml Platform Through Nonclinical Testing Expertise	CI
Jun. 18	Rothschild & Co Redburn Adjusts Charles River Laboratories International PT to $241 From $230, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-	-	-	-	-	-
LONZA GROUP AG						23
REVOLUTION MEDICINES, INC.						21
BEONE MEDICINES AG						27
IQVIA HOLDINGS INC.						19
CELLTRION, INC.						24
ASCENDIS PHARMA A/S		-		-		18
MEDPACE HOLDINGS, INC.						12
EUROFINS SCIENTIFIC SE						14
IONIS PHARMACEUTICALS, INC.						23
ICON PUBLIC LIMITED COMPANY						16
TEMPUS AI, INC.						15
BIO-TECHNE CORPORATION						13
ABIVAX						6
QIAGEN N.V.						14
PRAXIS PRECISION MEDICINES, INC.						18
ALKERMES PLC						16
KYMERA THERAPEUTICS, INC.						21
PROTAGONIST THERAPEUTICS, INC.						13
Average						17
Weighted average by Cap.						20